APA (7th ed.) Citation

Tran, L., Nikanjam, M., Capparelli, E. V., Bertino, J. S., Nafziger, A. N., Kashuba, A. D., . . . Ma, J. D. (2021). S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults. European journal of clinical pharmacology, 77(9), 1349-1356. https://doi.org/10.1007/s00228-021-03123-y

Chicago Style (17th ed.) Citation

Tran, Lana, Mina Nikanjam, Edmund V. Capparelli, Joseph S. Bertino, Anne N. Nafziger, Angela D.M Kashuba, Sandrine Turpault, and Joseph D. Ma. "S-warfarin Limited Sampling Strategy with a Population Pharmacokinetic Approach to Estimate Exposure and Cytochrome P450 (CYP) 2C9 Activity in Healthy Adults." European Journal of Clinical Pharmacology 77, no. 9 (2021): 1349-1356. https://doi.org/10.1007/s00228-021-03123-y.

MLA (9th ed.) Citation

Tran, Lana, et al. "S-warfarin Limited Sampling Strategy with a Population Pharmacokinetic Approach to Estimate Exposure and Cytochrome P450 (CYP) 2C9 Activity in Healthy Adults." European Journal of Clinical Pharmacology, vol. 77, no. 9, 2021, pp. 1349-1356, https://doi.org/10.1007/s00228-021-03123-y.